Tigermed
Asia, Zhejiang, China, Hangzhou'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Investor Profile
Tigermed has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series D (40%)
- Series B (20%)
- Series Unknown (20%)
- Series C (20%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Biopharma
- Manufacturing
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Tigermed frequently co-invest with?
Which angels does Tigermed often collaborate with?
What are some of recent deals done by Tigermed?
Find More Investors Like Tigermed
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
